Skip to content

Study of treatment for refractory sinusitis

Study of introduction of biological agents for refractory sinusitis - Introduction of biological agents for refractory sinusitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052699
Enrollment
50
Registered
2023-11-06
Start date
2021-07-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic sinusitis

Interventions

None listed

Sponsors

Tottori University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients diagnosed with chronic sinusitis 2)Patients with bilateral chronic sinusitis

Exclusion criteria

Exclusion criteria: 1)Patients who have refused to use their data 2)Patients undergoing treatment for malignant tumor. 3) Patients who are judged by the research director to be inappropriate as research subjects.

Design outcomes

Primary

MeasureTime frame
Frequency of surgical indications

Countries

Japan

Contacts

Public ContactYosuke Nakamura

Tottori University Hospital Otolaryngology, Head and Neck Surgery

yosuken@tottori-u.ac.jp0859-38-6627

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026